An article in a recent issue of The American Journal of Medicine by Chang et al1 indicated high risks of major bleeding in prescribing anticoagulants in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease.1 Though the study is professional in general, there are some critical methodological issues requiring further discussion.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023